Financial Statements

Overview

The report describes Hypera Pharma's 2022 financial performance, including Net Revenue of R\$7,546.4 million and 27.1% growth. It also covers acquisitions, innovation investments, and expansion of the Non-Retail Market. On sustainability, the company reports UN Global Compact participation, a Diversity & Inclusion Committee, the Juntos pelo Araguaia restoration project, and a CDP score improvement from C to B. The report points readers to a separate Sustainability Report for more detailed ESG data.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: Ends 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

CDP score

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services